
(Spencer Davislash, Unsplash)
According to the World Health Organization, tobacco is responsible for the death of 7 million people each year [1]. Although the addictive substance of tobacco is nicotine, it plays a minor role in smoking-related diseases [2]. As such, electronic nicotine delivery systems (ENDS) have been developed, of which electronic cigarettes (e-cigarettes) are the most common [3]. These products, also known as “vapes”, were first invented in 2003, by the Chinese pharmacist Hon Lik, quickly becoming a worldwide phenomenon. E-cigarettes were first sold in 2004, and in 2007 were introduced to the European and American markets. The quick dissemination of these products was caused by the labelling of e-cigarettes as a healthier and cheaper alternative to smoking, also working as a cessation aid [4]. These products have three basic components: a battery which provides energy to the electrical heater, which in turn produces aerosolized vapours from a liquid (e-liquid), inhaled by the user. The main components of the e-liquid are nicotine, flavouring agents and propylene glycol [3]. This last substance is linked with the alteration of “clock genes” [5], leading to unknown long term consequences. Nicotine is highly addictive, due to the stimulation of pleasure and reward pathways in the brain [2]. Thus, it induces pleasure, controls mood, and reduces stress and anxiety [2]. Moreover, it has diverse effects on the cardiovascular system, culminating in the increase of blood pressure {6], formation of atherosclerotic plaques, and modifications of the architecture of the heart [6], all possible factors that conduct to heart failure. In clear contrast to the conventional cigarettes, ENDS release aerosols, when the user exhales, making the “second hand” effects of e-cigarettes a possibility [7]. Furthermore, the surfaces that were exposed to ENDS vapours retain some nicotine, becoming a “third hand” source [8]. Up until 2014, there was no regulation regarding e-cigarettes. On February 26, 2014, the European Commission Directive published a statement about the safety and use of e-cigarettes [9]. Regarding the statements that e-cigarettes could be used as a smoking cessation aid, the conclusions are twofold: On the one hand, survey studies observe an increase of smoking cessation with the increase of e-cigarette use [10]. On the other hand, recent meta-analysis conclude that e-cigarette use is associated with reduced smoking cessation [11]. The scarier picture in this panorama is that ENDS might serve as an introduction to smoking to adolescents [12]. Even though youth smoking is declining in the same time period as the expansion of e-cigarettes, as it has been for the past decades, the correlation cannot be made with certainty. Furthermore, there was no clear sign of accelerated decrease of youth smoking since the introduction of the e-cigarette. In conclusion, e-cigarettes present themselves as a less harmful method of nicotine delivery than regular smoking. Although the consequences of long term use are unknown, e-cigarette use reduces the exposure to tobacco carcinogens and tar, which is beneficial. The most worrying topic about e-cigarettes might be their role as an introduction to smoking, considering adolescent use. References
- The WHO tobacco free initiative, Geneva, Switzerland. Cited April 25, 2019. https://www.who.int/en/news-room/fact-sheets/detail/tobacco
- Benowitz, N.L. 2010. Nicotine addiction. N. Engl. J. Med. 362: 2295–2303.
- The WHO tobacco free initiative, Geneva, Switzerland. Cited April 25, 2019. https://www.who.int/tobacco/communications/statements/eletronic-cigarettes-january-2017/en/
- Zhu, S.H. et al. 2014. Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob. Control 23: 3–9.
- Lechasseur A, Jubinville É, Routhier J, et al. Exposure to electronic cigarette vapors affects pulmonary and systemic expression of circadian molecular clock genes. Physiol Rep. 2017;5(19):e13440. doi:10.14814/phy2.13440
- Benowitz NL, Burbank AD. Cardiovascular toxicity of nicotine: Implications for electronic cigarette use. Trends Cardiovasc Med. 2016;26(6):515–523. doi:10.1016/j.tcm.2016.03.001
- Czogala J, Goniewicz ML, Fidelus B, Zielinska-Danch W, Travers MJ, Sobczak A. Second hand Exposure to Vapours from Electronic Cigarettes. Nicotine & Tobacco Research. Jun 2014;16(6):655-662.
- Goniewicz ML, Lee L. Electronic Cigarettes Are a Source of Thirdhand Exposure to Nicotine. Nicotine Tob Res. Aug 30 2014.
- European Parliment. Manufacture, presentation and sale of tobacco and related products. [2014 Feb 26; accessed 2019 April 26]. Available from: http://www.europarl.europa.eu/sides/getDoc.do?pubRef=-//EP//TEXT1TA1P7-TA-2014-0160101DOC1XML1V0//EN
- Zhu SH, Zhuang YL, Wong S, Cummins SE, Tedeschi GJ. E-cigarette use and associated changes in population smoking cessation: evidence from US current population surveys. BMJ. 2017;358:j3262. Published 2017 Jul 26. doi:10.1136/bmj.j3262
- Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med. 2016;4(2):116–128. doi:10.1016/S2213-2600(15)00521-4
- Soneji S, Barrington-Trimis JL, Wills TA, et al. Association Between Initial Use of e-Cigarettes and Subsequent Cigarette Smoking Among Adolescents and Young Adults: A Systematic Review and Meta-analysis. JAMA Pediatr. 2017;171(8):788–797. doi:10.1001/jamapediatrics.2017.1488
Discover more from The European Sting - Critical News & Insights on European Politics, Economy, Foreign Affairs, Business & Technology - europeansting.com
Subscribe to get the latest posts sent to your email.







































Why don't you drop your comment here?